Goldman Sachs Group Inc Bausch Health Companies Inc. Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
A detailed history of Goldman Sachs Group Inc transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 3,443,498 shares of BHC stock, worth $25.4 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,443,498
Previous 5,385,036
36.05%
Holding current value
$25.4 Million
Previous $37.5 Million
25.23%
% of portfolio
0.0%
Previous 0.01%
Shares
19 transactions
Others Institutions Holding BHC
# of Institutions
254Shares Held
253MCall Options Held
5.53MPut Options Held
16.5M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$257 Million2.88% of portfolio
-
Goldentree Asset Management LP New York, NY29.4MShares$217 Million21.8% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$195 Million14.7% of portfolio
-
National Bank Of Canada15.6MShares$116 Million0.18% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$96.1 Million0.26% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.67B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...